These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7905388)

  • 1. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
    Los LE; Coddington AB; Ramjit HG; Colby HD
    Drug Metab Dispos; 1993; 21(6):1086-90. PubMed ID: 7905388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs.
    Los LE; Colby HD
    Pharmacology; 1994 Feb; 48(2):86-92. PubMed ID: 8134406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.
    Los LE; Pitzenberger SM; Ramjit HG; Coddington AB; Colby HD
    Drug Metab Dispos; 1994; 22(6):903-8. PubMed ID: 7895608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone metabolism in target tissues. Characteristics of deacetylation in kidney, liver, adrenal cortex, and testes.
    Flowers NL; O'Donnell JP; Colby HD
    Drug Metab Dispos; 1989; 17(2):186-9. PubMed ID: 2565209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of spironolactone to 7 alpha-thiomethylspironolactone by hepatic and renal microsomes.
    LaCagnin LB; Lutsie P; Colby HD
    Biochem Pharmacol; 1987 Oct; 36(20):3439-44. PubMed ID: 3675606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of spironolactone by adrenocortical and hepatic microsomes: relationship to cytochrome P-450 destruction.
    Sherry JH; O'Donnell JP; Flowers L; Lacagnin LB; Colby HD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):675-80. PubMed ID: 3950869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples.
    Sandall JM; Millership JS; Collier PS; McElnay JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 839(1-2):36-44. PubMed ID: 16510319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone inhibition of cortisol production by guinea pig adrenocortical cells.
    Rourke KA; Colby HD
    Horm Metab Res; 1990 Nov; 22(11):573-5. PubMed ID: 2177032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic studies and bioavailability of bendroflumethiazide in combination with spironolactone].
    Vergin H; Nuss U; Strobel K
    Arzneimittelforschung; 1986 Mar; 36(3):490-5. PubMed ID: 3707669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.
    Karim A; Hribar J; Aksamit W; Doherty M; Chinn LJ
    Drug Metab Dispos; 1975; 3(6):467-78. PubMed ID: 1221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS.
    Dong H; Xu F; Zhang Z; Tian Y; Chen Y
    J Mass Spectrom; 2006 Apr; 41(4):477-86. PubMed ID: 16541392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulations.
    Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V; Martens H
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):334-40. PubMed ID: 9266289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of spironolactone to an active metabolite in target tissues: formation of 7 alpha-thiospironolactone by microsomal preparations from guinea pig liver, adrenals, kidneys, and testes.
    Sherry JH; O'Donnell JP; Colby HD
    Life Sci; 1981 Dec; 29(26):2727-36. PubMed ID: 7329203
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal mitochondrial metabolism of spironolactone. Absence of metabolic activation.
    Flowers NL; Sherry JH; O'Donnell JP; Colby HD
    Biochem Pharmacol; 1988 Apr; 37(8):1591-5. PubMed ID: 3358788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is canrenone the major metabolite of spironolactone?
    Merkus FW
    Clin Pharm; 1983; 2(3):209-10. PubMed ID: 6883952
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotransformations of the cardiovascular drugs mexrenone and canrenone.
    Preisig CL; Laakso JA; Mocek UM; Wang PT; Baez J; Byng G
    J Nat Prod; 2003 Mar; 66(3):350-6. PubMed ID: 12662091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the steroid 17 alpha-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450.
    Kossor DC; Kominami S; Takemori S; Colby HD
    Mol Pharmacol; 1991 Aug; 40(2):321-5. PubMed ID: 1875914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of spironolactone and its metabolites in human plasma.
    Jankowski A; Skorek-Jankowska A; Lamparczyk H
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1359-65. PubMed ID: 8818057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography.
    Krause W; Karras J; Jakobs U
    J Chromatogr; 1983 Oct; 277():191-9. PubMed ID: 6643605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of microsomal spironolactone metabolism by reduced glutathione.
    Colby HD; LaCagnin LB; Los LE
    Pharmacology; 1996 Jan; 52(1):30-4. PubMed ID: 8966200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.